Not a member? Sign up for free!

Meeting The Challenges In Caring For Patients With Schizophrenia: Roles Of The Pharmacist

Webinar | December 15, 2016 12:00 pm to 1:00 pm EST
You must be logged in to register for PsychU events.

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

Description

Virtual Forum: Meeting The Challenges In Caring For Patients With Schizophrenia: Roles Of The Pharmacist

Location: Online Via PsychU.org

Description: Addressing the challenges of caring for patients with schizophrenia in terms of treatment, recovery, and remission requires a coordinated effort across all members of a treatment team. The role of pharmacist in treating schizophrenia has expanded in recent years, with pharmacists taking a more active role in identifying the best treatment options for individual patients. In this virtual forum, Dr. Lawrence J. Cohen and Dr. Larry Ereshefsky will provide the pharmacist’s perspective on the current challenges and roles of pharmacists in treating schizophrenia, identify important considerations in monitoring metabolic wellness, and review new and emerging research in treating schizophrenia. The virtual forum will conclude with time for questions from the audience.
Drs. Cohen and Ereshefsky are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

Event Speakers

Lawrence J. Cohen, PharmD, FASHP, FCCP, FCP, BCPP
Featured Speaker

Professor of Pharmacotherapy at the University of North Texas Health Science Center and over 25 years of experience in professional and postdoctoral residency education primarily focused on psychiatric and neurological disorders.

Larry Ereshefsky, PharmD, FCCP, BCPP
Featured Speaker

Recently retired Vice President of Early Phase & CNS Global Therapeutic Area Leader at Parexel, with over 13 years of experience as an Executive, Chief Scientific Officer, or Lead Clinical Scientist for Early Phase CNS.

The registration for this event is now closed. For more information about our live event registration process, please read the Live Event Eligibility Requirements